![]()
MIRA INFORM REPORT
|
Report Date : |
24.08.2011 |
IDENTIFICATION DETAILS
|
Name : |
SUHEUNG CAPSULE CO., LTD. |
|
|
|
|
Formerly Known As : |
SUHEUNG CHEMICAL INDUSTRIAL CO., LTD. |
|
|
|
|
Registered Office : |
317, Songnae 1-dong, Sosa-gu, Bucheon-si, Gyeonggi-do, Korea, Zip Code 422-814 |
|
|
|
|
Country : |
South Korea |
|
|
|
|
Financials (as on) : |
30.06.2011 |
|
|
|
|
Date of Incorporation : |
30.01.1973 |
|
|
|
|
Com. Reg. No.: |
130-81-00576 |
|
|
|
|
Legal Form : |
Listed Company |
|
|
|
|
Line of Business : |
Manufacture of Medicinal Medicaments |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment
Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
South Korea |
a1 |
a1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Company Name |
SUHEUNG CAPSULE CO., LTD. (Korean Company Name : “(주)서흥캅셀”) |
|
Registered Address |
317, Songnae 1-dong, Sosa-gu, Bucheon-si,
Gyeonggi-do, Korea |
|
Zip Code |
422-814 |
|
Tel |
+82-32-610-7100 |
|
Fax |
+82-32-666-0189 |
|
E-mail |
|
|
Website |
|
|
Trading Address |
6th Fl., Jung-An Bldg., 435-5, Jangan
3-dong, Dongdaemun-gu, Seoul, Korea |
|
Tel |
+82-2-2210-8175 |
|
Fax |
+82-2-2217-2356 |
|
Other Address-2nd Factory |
1731-4, Songjeong-dong, Gangseo-gu, Busan,
Korea |
|
Tel |
+82-51-831-8803 |
|
Fax |
+82-51-831-8806 |
|
Type |
Export |
|
Industry |
Manufacture of Medicinal Medicaments |
|
Main Business |
Empty Hard Capsules, Soft Capsule, Health Food, Encapsulation Machine |
|
Established (mm/dd/yyyy) |
01/30/1973 |
The Subject owns
the premises of the registered address/Factory(18,142m2) and 2nd
Factory(13,386m2).
|
Activity |
Detailed Products (UNSPSC) |
|
Sell |
Capsule tubes or caps(24141709) |
|
Sell |
Health & Nutrition Food |
|
Sell |
Hard Capsule |
|
Sell |
Soft Capsule |
|
Sell |
Automatic Capsule Filling Machine |
|
Sell |
Paint Ball |
|
Name |
Yang Joo-Hwan |
|
Date of Birth |
03/13/1952 |
|
Title |
President & CEO |
|
Sex |
Male |
|
Nationality |
Korean |
|
Capital (KRW) |
6,084,556,500 |
|||||||||||||||||||||
|
Employees |
581 |
|||||||||||||||||||||
|
Formation |
Listed Company (Korea Stock Exchange: 008490) as of 03/27/1990 A Company of SUHEUNG CAPSULE CO., LTD. |
|||||||||||||||||||||
|
Bank Details |
Citi Bank, Korea-HQ Branch Kookmin Bank Korea Development Bank Hana Bank Woori Bank |
|||||||||||||||||||||
|
Corporate Registered No. |
124311-0004252 |
|||||||||||||||||||||
|
Business Registered No. |
130-81-00576 |
|||||||||||||||||||||
|
Permit & Licenses |
01/03/1998 ISO 9001 Patent(26161) : EMBO CAPS Int’l Trade No.: 814492 |
|||||||||||||||||||||
|
Shareholder Position |
|
|||||||||||||||||||||
|
Company History |
01/30/1973 Incorporated as SUHEUNG CHEMICAL
INDUSTRIAL CO., LTD. 01/30/1980 Changed company name to the
present name 06/01/1982 Acquired Jinhung Pharm. Co.,
Ltd. 03/27/1990 Listed at KSE Market 11/30/1992 Awarded US$5 Million Export Top
Prize 11/30/1994 Awarded US$10 Million Export Top
Prize 11/30/2003
Awarded US$20 Million Export Top Prize 11/30/2008
Awarded US$30 Million Export Top Prize |
|||||||||||||||||||||
|
|
|
|
Job Description |
Title |
Name |
Nationality |
Date of Birth |
Education |
|
President & CEO |
Mr. |
Yang Joo-Hwan |
Korean |
1952.03.13 |
Yonsei University, Korea |
|
Vice President |
Mr. |
Yoon Sung-Gerl |
Korean |
1952.02.10 |
Kyungbuk National University, Korea |
|
Executive Director |
Mr. |
Kim Bae-Sung |
Korean |
1951.01.20 |
Dankuk University, Korea |
|
Outside Director |
Mr. |
Lee Byung-Kil |
Korean |
1937.06.15 |
Myungji University, Korea |
|
Auditor |
Mr. |
Kim Kwang-Yon |
Korean |
1939.04.08 |
Myungji University, Korea |
|
Auditor |
Mr. |
You Young-Keun |
Korean |
1954.02.11 |
Hankuk University of Foreign Studies, Korea |
|
Year / Unit : KRW |
Sales |
Assets |
Net Income |
|
73,004,223,083 |
314,507,690,014 |
8,577,589,377 |
|
|
2010 |
124,860,736,612 |
264,037,146,738 |
13,967,924,362 |
|
2009 |
107,816,084,492 |
174,448,247,930 |
12,341,777,483 |
|
2008 |
101,606,218,474 |
171,911,838,049 |
10,640,188,356 |
|
2007 |
82,180,764,151 |
165,845,450,904 |
11,452,762,741 |
|
2006 |
76,710,971,354 |
138,611,568,949 |
2,953,156,089 |
|
2005 |
79,038,672,652 |
134,356,104,317 |
10,190,368,933 |
|
2004 |
67,146,608,615 |
97,988,295,464 |
4,225,936,857 |
|
2003 |
61,617,857,772 |
88,006,173,647 |
5,053,581,380 |
(*)06/2011 and 2010’s figures are based on the K-IFRS Accounting System.
|
Authorized Capital(KRW) |
20,000,000,000 |
|
Paid-Up Capital(KRW) |
6,084,556,500 |
|
Total Issues Shares |
12,169,113 |
Balance
Sheet
|
|||
|
Unit : Korean Won |
01/01/2011~06/30/2011 |
As of 12/31/2010 |
As of 12/31/2009 |
|
Total Assets |
314,507,690,014 |
256,441,670,003 |
|
|
Current Assets |
87,930,213,680 |
64,608,267,746 |
|
|
Cash & Cash
Equivalents |
15,983,166,096 |
4,058,465,256 |
|
|
Trade Receivables |
38,450,018,332 |
33,244,085,385 |
|
|
Inventories |
28,801,529,998 |
26,593,968,149 |
|
|
Short-Term Receivables |
4,376,542,887 |
620,722,298 |
|
|
Other Current Assets |
318,956,367 |
91,026,658 |
|
|
Non-Current Assets |
226,577,476,334 |
191,833,402,257 |
|
|
Non-Current Financial Instruments |
1,203,482,554 |
1,574,716,493 |
|
|
Marketable Financial Instruments |
23,016,000 |
581,611,000 |
|
|
Other Financial Instruments |
400,000,000 |
400,000,000 |
|
|
Investment_Related Companies |
29,461,509,896 |
29,445,029,896 |
|
|
Investment_Real Estates |
1,678,607,619 |
2,974,378,190 |
|
|
Tangibles |
183,151,337,097 |
146,080,332,799 |
|
|
Intangibles |
2,975,078,109 |
2,968,478,109 |
|
|
Long-Term Trade Receivables |
7,684,445,059 |
7,808,855,770 |
|
|
Total Liabilities |
141,280,992,744 |
90,871,548,352 |
|
|
Current Liabilities |
80,991,900,418 |
63,434,320,883 |
|
|
Trade Payables |
3,961,873,048 |
5,611,219,571 |
|
|
Short-Term Borrowings |
67,186,061,800 |
53,060,000,000 |
|
|
Short-Term Liabilities |
5,934,126,612 |
1,616,802,087 |
|
|
Accrued Income Tax |
2,436,490,936 |
2,575,147,142 |
|
|
Other Current Liabilities |
1,473,348,022 |
571,152,083 |
|
|
Non-Current Liabilities |
60,289,092,326 |
27,437,227,469 |
|
|
Long-Term Trade Payables & Other Payables |
50,391,058,220 |
16,234,750,000 |
|
|
Provision for Severance & Retirement |
7,021,126,292 |
6,221,005,997 |
|
|
Deferred Income Tax Credit |
9,556,200,776 |
9,584,477,469 |
|
|
Other Long-Term Payables |
341,833,330 |
1,618,000,000 |
|
|
Capital
Stock |
6,084,556,500 |
6,084,556,500 |
|
|
Capital Surplus |
38,377,468,436 |
38,377,468,436 |
|
|
Others |
3,122,903,456 |
944,565,574 |
|
|
Profit Surplus |
125,641,768,878 |
120,163,531,141 |
|
|
Total Equity |
173,226,697,270 |
165,570,121,651 |
|
|
Liab.
& Shareholder’s Equity |
314,507,690,014 |
256,441,670,003 |
|
|
Balance Sheet |
|||
|
Unit : Korean Won |
As of 12/31/2010 |
As of 12/31/2009 |
As of 12/31/2008 |
|
Total Assets |
264,037,146,738 |
174,448,247,930 |
171,911,838,049 |
|
Current Assets |
72,884,004,188 |
66,677,858,988 |
70,417,976,708 |
|
-Quick Assets |
46,290,036,039 |
43,503,599,789 |
49,771,143,887 |
|
-Inventories |
26,593,968,149 |
23,174,259,199 |
20,646,832,821 |
|
Fixed Assets |
191,153,142,550 |
107,770,388,942 |
101,493,861,341 |
|
-Investment |
39,546,092,529 |
38,490,473,487 |
35,320,994,738 |
|
-Tangibles |
148,238,399,912 |
64,720,753,722 |
62,056,709,492 |
|
-Intangibles |
496,900,000 |
496,900,000 |
1,451,900,000 |
|
-Others |
2,871,750,109 |
4,062,261,733 |
2,664,257,111 |
|
Total Liabilities |
90,851,813,411 |
52,971,863,307 |
59,717,326,070 |
|
Current Liabilities |
63,434,320,883 |
47,755,914,796 |
31,311,600,345 |
|
Fixed Liabilities |
27,417,492,528 |
5,215,948,511 |
28,405,725,725 |
|
Capital Stock |
6,084,556,500 |
6,084,556,500 |
5,902,740,000 |
|
Capital Surplus |
44,442,277,170 |
44,442,277,170 |
42,562,310,093 |
|
Profit Surplus |
85,236,747,050 |
74,036,100,938 |
64,156,583,855 |
|
Capital Adjustment |
37,421,752,607 |
-3,086,549,985 |
-427,121,969 |
|
Total Equity |
173,185,333,327 |
121,476,384,623 |
112,194,511,979 |
|
Liab. & Shareholder’s Equity |
264,037,146,738 |
174,448,247,930 |
171,911,838,049 |
Income
Statement
|
|||
|
Unit : Korean Won |
01/01/2011~06/30/2011 |
As of 12/31/2010 |
As of 12/31/2009 |
|
Sales |
73,004,223,083 |
|
|
|
Cost
of Sold Goods |
55,023,658,311 |
|
|
|
Gross
Profit |
17,980,564,772 |
|
|
|
Selling
& Admin. Expenses |
5,836,679,042 |
|
|
|
Operating
Income |
12,143,885,730 |
|
|
|
Investment Income on Related companies |
428,400,000 |
|
|
|
Finance
Income |
410,925,880 |
|
|
|
Finance
Expenses |
2,704,558,173 |
|
|
|
Other
Operating Income |
678,559,037 |
|
|
|
Other
Operating Expenses |
177,052,951 |
|
|
|
Income
Before Taxes |
10,780,159,523 |
|
|
|
Income
Taxes Expenses |
2,202,570,146 |
|
|
|
Net
Income |
8,577,589,377 |
|
|
|
Income Statement |
|||
|
Unit : Korean Won |
As of 12/31/2010 |
As of 12/31/2009 |
As of 12/31/2008 |
|
Sales |
124,860,736,612 |
107,816,084,492 |
101,606,218,474 |
|
Cost of Sold Goods |
94,258,062,170 |
77,960,506,776 |
72,612,854,477 |
|
Gross Profit |
30,602,674,442 |
29,855,577,716 |
28,993,363,997 |
|
Selling & Admin. Expenses |
11,608,169,343 |
10,101,958,229 |
10,978,363,158 |
|
Operating Income |
18,994,505,099 |
19,753,619,487 |
18,015,000,839 |
|
Non-Operating Income |
11,822,507,151 |
5,849,155,686 |
7,536,011,723 |
|
Non-Operating Expenses |
13,477,312,602 |
9,378,393,309 |
10,832,356,034 |
|
Income Before Taxes |
17,339,699,648 |
16,224,381,864 |
14,718,656,528 |
|
Income Taxes Expenses |
3,371,775,286 |
3,882,604,381 |
4,078,468,172 |
|
Net Income |
13,967,924,362 |
12,341,777,483 |
10,640,188,356 |
Cash
Flows
|
|||
|
Unit : Korean Won |
01/01/2011~06/30/2011 |
As of 12/31/2010 |
As of 12/31/2009 |
|
Operating
Activities Cash Flows |
-3,354,680,052 |
|
|
|
Net Income |
8,577,589,377 |
|
|
|
Adjustment |
-7,726,476,904 |
|
|
|
Interests Received |
72,040,390 |
|
|
|
Interests Paid |
-1,702,685,773 |
|
|
|
Income Taxes |
-2,575,147,142 |
|
|
|
Cash Flows from Investing |
-31,143,713,473 |
|
|
|
Cash Flows from Financing |
46,437,562,708 |
|
|
|
Increase/Decrease in Cash |
11,924,700,840 |
|
|
|
Cash at the Beginning of Year |
4,058,465,256 |
|
|
|
Cash at the End of Year |
15,983,166,096 |
|
|
|
Cash Flows |
|||
|
Unit : Korean Won |
As of 12/31/2010 |
As of 12/31/2009 |
As of 12/31/2008 |
|
Cash Flows
from Operating |
9,134,132,813 |
14,120,443,185 |
8,238,681,991 |
|
-Net Income |
13,967,924,362 |
12,341,777,483 |
10,640,188,356 |
|
-Exp. without
Cash Outflow |
17,170,994,238 |
12,712,602,847 |
10,560,663,840 |
|
-Revenue
without Cash Inflows |
-9,712,235,481 |
-4,104,195,694 |
-3,564,170,914 |
|
-Changes in
Asset/ & Liability |
-12,292,550,306 |
-6,829,741,451 |
-9,397,999,291 |
|
Cash Flows
from Investing |
-34,789,980,681 |
-6,464,370,100 |
2,367,602,150 |
|
-Cash Inflow
from Investing |
18,228,786,228 |
16,433,458,993 |
44,767,395,427 |
|
-Cash
Outflows for Investing |
-53,018,766,909 |
-22,897,829,093 |
-42,399,793,277 |
|
Cash Flows
from Financing |
28,616,125,564 |
-9,831,619,029 |
-8,298,729,548 |
|
-Cash
Inflows from Financing |
148,588,741,700 |
56,627,650,000 |
41,705,928,652 |
|
-Cash
Outflows from Financing |
-119,972,616,136 |
-66,459,269,029 |
-50,004,658,200 |
|
Increase/Decrease
in Cash |
2,960,277,696 |
-2,175,545,944 |
2,307,554,593 |
|
Cash at the
Beginning of Year |
1,098,187,560 |
3,273,733,504 |
966,178,911 |
|
Cash at the End of Year |
4,058,465,256 |
1,098,187,560 |
3,273,733,504 |
|
Main Products & Services |
Empty Hard Capsules, Soft Capsule, Health Food, Encapsulation Machine,
Paintball for Leisure Brand Name: EMBO CAPS |
||||||||
|
Annual Production Capacity (Unit: Million EA) |
|
|
Suppliers |
GELITA SWEDEN AB PB LEINER USA GELTECH CO., LTD(180111-0262476) BMW FINANCIAL SERVICES KOREA CO., LTD.(110111-2278756) provides
vehicle leasing services to the Subject company. |
|
Customers |
Major Pharmaceutical companies and
manufacturers |
|
Competitors |
HAN KOOK CAPSULE INDUSTRY CO., LTD. 13-164, SEONGSU 1-GA 2-DONG, SEONGDONG-GU,
SEOUL, KOREA TEL:+82-2-464-0621 FAX:+82-2-464-9503 |
(Subsidiaries, Joint-Venture & Affiliates)
|
Affiliates |
GELTECH CO., LTD(180111-0262476) (42.84% held by the subject company) SH PHARM. CO., LTD.(121111-0112531) (100.00% held by the subject company) SH PHARACEUTICAL CO., LTD.(110111-3256214) (26.26% held by the subject company) SUHUNG PLAZMA CO., LTD.(110111-2003567) (36.19% held by the subject company) NUTROJIN CO., LTD.(110111-3388215) (30.00% held by the subject company) UNI-CAPS CO., LLC. (50.00% held by JUMBO CAPSULE) |
|
Overseas Office |
SUHEUNG-VIETNAM CO., LTD 3RD FLOOR, ROOM 6, 268 TO HIEN THANH ST.,
WARD 15, DIST 10, HCMC. VIETNAM TEL:+84-83-868-1363 FAX:+84-83-868-1366 SUHEUNG-EUROPE REPRESENTATIVE OFFICE A. SENOE 3 VARAZDIN 42000 CROATIA TEL:+38-599-509-8469 FAX:+38-542-71-2212 SUHEUNG-AMERICA CORPORATION 350 RANGER AVE. UNIT A BREA, CA, 92821 TEL:+1-714.996.7700 FAX:+1-714.996.7100 SUHEUNG-JAPAN CO., LTD. POST CODE 101-0035 SUZUNO BLDG. 3F 11
BANCHI, KANDA-KONYACHO, CHIYODA-KU, TOKYO, JAPAN TEL:+81-3-5256-7501 FAX:+81-3-5256-8008 |
|
Subsidiary |
GELTECH CO., LTD(180111-0262476) (42.84% held by the subject company) SUHUNG PLAZMA CO., LTD.(110111-2003567) (36.19% held by the subject company) SUHEUNG-AMERICA CORPORATION (100.0% held by the subject company) SUHEUNG-VIETNAM CO., LTD (100.00% held by the subject company) SUHEUNG-JAPAN CO., LTD. (100.00% held by the subject company) SH PHARM. CO., LTD.(121111-0112531) (100.00% held by the subject company) |
|
Cooperative
Enterprise-Agent |
INGREDIENTS PLUS UNIT 8,7-11 SOUTH STREET RYDALMERE NSW 2116
AUSTRALIA TEL:+61-2-96846788, FAX:+61-2-96846799 E-MAIL : M.PETROS@INGREDIENTSPLUS.COM.AU BUSINESS POINT LTD. TMC BUILDING 8TH FLOOR, 52, NEW ESKATON
ROAD G.P.O BOX NO.2034 DHAKA-1000 BANGLADESH. TEL:+832 1712 , 832 1909 ,
FAX:+880-2-8321255, 880-2-8317218 E-MAIL : BP_Z@DHAKA.BANGLA.NET 5040 SERVICES LTD PO BOX 794, SOFIA BG-1000, BULGARIA TEL : 359 -2 -971- 6420 FAX:+359 - 2 - 971 - 6421 HOMEPAGE : WWW.5040SERVICES.COM DISPERGAL LTD. P.O.BOX 1795, DOROTHEA BLDG., 33 THEKLAS
LYSSIOTI STR., LIMASSOL-CYPRUS. TEL:+357-25-566490, FAX:+357-25-562481 E-MAIL : EVIE.PEKLIVANA@DISPERGAL.COM WELDING PHARMA FRANCE 22, AVENUE RENE CASSIN 69009LYON FRANCE TEL:+(33) (0) 4 7864 2323 , FAX:+33) (0)4
78 83 73 10 WELDING GMBH & CO POST BOX 305840, 20318 HAMBURG ESPLANADE 39
20354 HAMBURG, GERMANY TEL:+49 40 35 908 179 , FAX:+49 40
35908-4179 |
|
Cooperative
Enterprise-Agent |
MARIA A. STAMENY P.O.BOX 17 111 GR 100.24 ATHENS GREECE TEL:+30-210-361-0018, FAX:+30-210-362-9898 E-MAIL : STAMM@OTENET.GR HUKONG & COMPANY RM1402, 14 FLOOR, WATERLOO PLAZA, 53-55
WATERLOO RD., KOWLOON, HONG KONG TEL:++23849478 FAX:+23849486 EMAIL: HUKONG@PACIFIC.NET.HK JAGSON ENGINEERS A/113, OSHIWARA INDUSTRIAL CENTRE, OPP.
OSHIWARA BUS DEPOT, OFF. LINK ROAD, GOREGAON(WEST), MUMBAI 400 104. INDIA TEL:+91-22-2879-2182, FAX:+91-22-2879-2192 PT NARDA TITA KOMPLEK PURI NIAGA 3 BLOK M8/NO. 3C JI PURI
KENCANG-KEMBN SELATAN JAKARTS BARAT 11610, INDONESIA. TEL:+5830-3475, FAX:+5830-3473 E-MAIL : NARDA97@CBN.NET.ID FAHYM KALA CO., LTD. 1ST FL., 108 EBNESINA ST., YOUSEF ABAD
14346, P.O.BOX, 14335-466, TEHRAN, IRAN. TEL:+21-8067021~3 , FAX:+21-879 3832 E-MAIL : INFO@FAHYMKALA.COM INTACT CHEM. LTD SHRAGA REPHAELI.20/56, PETAH TIKVA 49064, ISRAEL TEL:+972 3 91 90 644 FAX:+ 972 3 91 90 644 E-MAIL : MICHAELE@BARAK.NET.IL |
|
Cooperative
Enterprise-Agent |
PRODOTTI
GIANNI S.P.A. VIA
QUINTILIANO, 30. 20138 MILAN - ITALY TEL : (39
02) 509 7218, FAX:+(39 02) 7313 HIGUCHI INC. 3-24-18
TAKANAWA MINATO-KU TOKYO JAPAN TEL :
5420-5530 FAX:+5791-7125 CALDIC
INGREDIENTS B.V. ELWENWEG 5,
NL-3421 TT P.O. BOX 106, NL-3420 DC OUDEWATER THE NETHERLANDS TEL:++31-348-566-656(DIR)
FAX:++31-348-566-646 CAPROMAX
SDN. BHD. NO. 60,
JALAN WAWASAN 3/3, PUSAT BANDAR PUCHONG, 47100 PUCHONG, SELANGOR, MALAYSIA. TEL:++60 12
209 1311 FAX:++60 12 299 4708 E-MAIL :
HC_WONG@MYJARING.NET GUDIA
(PRIVATE) LIMITED 6TH FLOOR,
MEHDI TOWERS, 115-A, S.M.C.H.S.,SHAHRAH-E-FAISAL, KARACHI-PAKISTAN. TEL:+(92-21)
4539101~5 , FAX:+(92-21) 4556613/3734 E-MAIL :
GUDIA@CYBER.NET.PK PHARMACAPS,
INC. HEAD OFFICE:
NO.1 UNIT D. 2ND., CORNER SAN RAFAEL, ST., BO. KAPITOLYO, PASIG CITY
PHILIPPINES TEL :
633-6177 , FAX:+633-6177 |
|
Cooperative
Enterprise-Agent |
MDLD
INTERNATIONAL, INC. NO.73 SCOUT
FERNANDEZ QVEZON CITY TEL :
372-3984, FAX:+372-3425 NOVAWES
IMPORT (PTY) LTD. PO BOX 97518
PETERVALE 2151, SOUTH AFRICA TEL :
27-11-463-6507, FAX:+27-11-463-1574 E-MAIL :
NOVAWES@GLOBAL.CO.ZA IMPEX
QUIMICA, S.A. LLUCA, 28
08028 BARCELONA (SPAIN) TEL : +34 93
409 9070, FAX:++34 93 399 2162 SHAFT TRADE
INST. ALEPPO-SYRIA,
AI-GABRIA-DEMITRIOUS ST. BLOCK 7-2ND FLOOR. P.O. BOX 6719 SYRIA TEL: +963 21
4602599 THOI
MEOCHEMS CO., LTD. 53/1-2 SOI
WUTTAKAD 3, WUTTAD RD., TRADPHU, THONBURI, BANGKOK 10600, THAILAND TEL:
66-2891-5514, FAX:+66-2891-5552 E-MAIL :
KORNSIRI@CSLOXINFO.COM LEVI DIS
TICARET A.S. KEMERALTI
CAD NO.2 ONEY IS HANI KAT 5 KARAKYY, 80030 ISTANBUL TURKEY. TEL:
251-7520 , FAX:+251-5840/41 E-MAIL :
FILIZ@LEVI.COM.TR |
|
Cooperative
Enterprise-Agent |
PLUSPHARMA
INCORPORATED 2460 CORAL
STREET VISTA, CA 92081, U.S.A TEL:
(760)597-0200, FAX:+(760) 597-0734 E-MAIL :
JENNIFERO@PLUSPHARM.COM CORNELIUS
GROUP CORNELIUS
HOUSE, WOODSIDE, DUNMOW ROAD, BISHOP'S STORTFORD, HERTFORDSHIRE, CM23 5RG,
U.K. TEL: (01279)
714 316 , FAX:+(01279) 714 320 SUHEUNG
INTERNATIONAL 243/1/26 TO
HINEN THANH, WARD 13, DIST 10, HCMC. TEL :
84-8-293-4229 FAX: 84-8-862-3449 E-MAIL :
KOOCHUL9@NETIAN.COM MASKEM
ALGERIE LOT ALI
BENDALI N°58, DERGANA WILAYA D'ALGER CP/16411, ALGERIE TEL:+ 213 21
21 68 68 E-MAIL :
LOTFI.OUDINA@MASKEM.COM MASKEM EGYPT 5 EL-WATANIA
BUILDINGS -SEFARAT DISTRICT-NASR CITY,CAIRO EGYPT TEL +202
6720201 / +202 6720202 FAX +202 6720203 E-MAIL :
AMRBADAWI@MASKEMEGYPT.COM MASKEM
MIDDLE EAST AL-RABIA,
CABOL STREET AL-GAZHAL BUILDING, 1ST FLOOR AMMAN - JORDAN TEL : 00 962
6 55 48 46 2 / 3 FAX:0096265548439 E-MAIL :
ALIA.QARAIN@MASKEM.COM MASKEM
MOROCCO 484,BD
BRAHIM ROUDANI 1°ETAGE, APPT N° 2, MAARIF 20100
CASABLANCA- ANFA, MOROCCO TEL : 00212
61 19 40 88 FAX 00 212 22 98 62 01 E-MAIL :
REDOUANE.KHAMMAL@MASKEM.COM MASKEM GULF
FZCO BUILDING LOB
14 OFFICE 218 JEBEL ALI FREE ZONE P.O.BOX 18453 DUBAI, UAE TEL: +971 4
887 30 71 FAX:+971 4 887 30 72 EMAIL:
WAEL.GAAMA@MASKEM.COM |
|
Cooperative
Enterprise |
-Insured
Company DONGBU INSURANCE CO., LTD.(110111-0095285) LIG INSURANCE CO., LTD(110111-0017859) KOREA LIFE INSURANCE CO.,
LTD.(110111-0003204) |
(Activity & Markets)
|
Sales/ Unit :Mil KRW |
(*)06/2011 |
2010 |
2009 |
|
Export |
17,369 |
34,215 |
35,297 |
|
Domestic |
55,635 |
90,646 |
72,519 |
|
Total |
73,004 |
124,861 |
107,816 |
---
---
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.69 |
|
UK Pound |
1 |
Rs.75.29 |
|
Euro |
1 |
Rs.65.77 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.